BoD & SCAP LOGIN

Partners & Exhibitors

Many thanks to the following companies for providing grants in support of the medical education portion of the 2023 APA Scientific Conference:


 

 

ExhibitorsDescription

AbbVie’s mission is to discover and deliver innovative medicines and solutions for today’s health issues and tomorrow’s medical challenges, striving to have a remarkable impact on people's lives across key therapeutic areas and our aesthetics portfolio.

www.abbvie.com

The AMA offers education and support to help member physicians and billing staff understand the Alberta Schedule of Medical Benefits (SOMB). Members can contact billingadvice@albertadoctors.org with their claims-related questions.

https://www.albertadoctors.org

The APA Foundation was created in 2008 to raise funds for education and research in the field of mental health. Your donations will help the APA Foundation bring noted speakers to present at future APA Conferences while still keeping registration fees low so as to encourage full industry participation and education

https://albertapsych.org/foundation/

APOTEX - as a proudly Canadian-based global health company for almost 50 years, we are dedicated to meeting high standards and committed to delivering high quality products made in Canada, by Canadians, for Canadians. Apotex is proud of its legacy commitment with the psychiatric community and will continue delivering the very best for Canadian patients.

https://www.apotex.com

Eisai is a R&D company that seeks innovative solutions in disease prevention, treatment, and care in Neurology and Oncology.  Dayvigo is the only Orexin receptor antagonist indicated for the treatment of Insomnia in Canada.

https://ca.eisai.com/

Elvium Life Sciences is a pharmaceutical company passionately committed to improving the health and quality of life of Canadians through innovative medicines in specific therapeutic disease areas of need and importance. Elvium Life Sciences focuses on our existing products in the areas of CNS (ADHD) and ophthalmic conditions while continuing to seek to deliver new therapies to meet the needs of Canadians.

https://elvium.ca/

HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments, devices and diagnostics critical to Health Care Providers, patients and their caregivers with the brand names they trust.

www.hlstherapeutics.com

Janssen Inc., a pharmaceutical company of Johnson & Johnson, has been an innovator in the Canadian healthcare industry for over 50 years.  We are guided by Our Credo, where our first responsibility is to the doctors, nurses and patients, and mothers and fathers, and all others who use our products and services. Our ultimate goal is to help people live healthy lives. Janssen’s history and our values provide the focus for our contributions to healthcare today and in the future. We have treatments within the divisions of Oncology, Immunology, Neurosciences, Infectious Diseases and Vaccines, Cardiovascular and Metabolic Diseases.

http://www.janssen.com/canada/

We know the brain.

Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. We believe life is too beautiful to be interrupted by brain disorders. So, we pursue imaginative solutions, driven by passionate people committed to do the right thing for our patients, our company and our communities. For Lundbeck, making a meaningful difference for those with lived experience is more than an aspiration: it is a commitment that shapes everything we do. Our advocacy is at the core of who we are and motivates every individual at Lundbeck. Our ongoing engagement with patient communities is not what you might expect from a pharmaceutical company - we work with organizations to help empower people. We believe in challenging the status quo, because Canadians living with brain disorders deserve better.

http://www.lundbeck.com

Otsuka-people creating new products for better health worldwide

Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, cardiovascular, and oncology. OCPI is dedicated to improving patients' health and the quality of human life. OCPI is part of the Otsuka Group, and was established in 2010, with headquarters in Technoparc Montreal, in Saint-Laurent, Quebec.

www.otsukacanada.com

The Physician and Family Support Program (PFSP)- a voluntary program that provides confidential support and help with personal health issues. Part of the AMA’s physician benefits program, PFSP enhances the quality of patient care and public safety by supporting the health and well-being of the medical profession that cares for all Albertans.

https://www.albertadoctors.org/services/pfsp

Don't forget to book your timeslot to get your photos taken on Saturday, March 23rd!

Arrive anytime during your booked timeslot and present your ticket!

Digital photos will be recieved via email when they are ready.

Viatris is the sole provider of clozapine originator brand in all countries outside of North America – allowing us to share the best clozapine practices worldwide. In Canada, Viatris markets Gen-Clozapine and has provided exceptional patient care through our Gen-Clozapine Access Network (GenCAN) for over 18 years.

https://www.viatris.com/en